Frontiers in Oncology · 2021 · 17 citations · 25 references
MedicineEndocrinologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingRadioiodine TherapySignal Transduction In CancerThyroid CancerThyroid DisordersThyroid EndocrinologyIodide UptakeNuclear Thyroid Hormone SignalingThyroid Cancer PathologyThyroid Hormone Receptor SignalingThyroid-stimulating Hormone Receptor Signaling
Iodide uptake and the metabolism of thyroid cells are regulated by thyrotropin (TSH)-TSH receptor (TSHR) signaling. Thus, it is necessary to elevate serum TSH levels by T4 withdraw or rTSH administration to facilitate radioiodide ( 131 I) therapy for differentiated thyroid cancer (DTC). However, non-iodide-avid metastases of DTC which is dedifferentiated do not respond to stimulation by high levels of TSH, suggesting abnormal TSH-TSHR signal transduction in cancer cells. In addition, PI3K/AKT/mTOR signaling activation has been shown to be associated with the dedifferentiated phenotype of thyroid cancer, but the mechanism remains elusive. Therefore, in this study, we aimed to explore the role of abnormal TSH-TSHR signaling activation in regulating iodide uptake and cell mobility in thyroid cancer and its relationship with PI3K/AKT/mTOR signaling. We found that in thyroid cancer cells, TSH binds TSHR coupled to the Gα 12/13 protein and then activates RhoA through interacting with leukemia associated RhoA guanine exchange factor (LARG). This results in a promigration tumorigenic phenotype independent of canonical TSHR-Gα S signaling that regulates the expression of molecules involved in iodine uptake and metabolism. We observed that signaling pathways downstream of Gα 12/13 signaling were increased, while that of Gα s signaling was decreased in thyroid cancer cells undergoing dedifferentiation compared to control cells following stimulation with different levels of TSH. PI3K/AKT/mTOR signaling activation enhanced Gα 12/13 signaling through increasing LARG levels but also inhibited the expression of molecules downstream of Gα s signaling, including thyroid-specific molecules, and iodide uptake. In summary, our results demonstrate the noncanonical activation of TSH-TSHR signaling and its role in increasing the cell mobility and dedifferentiation of thyroid cancer through crosstalk with PI3K/AKT/mTOR signaling.
25
Cosimo Durante, Nadia Haddy, E. Baudin et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 1.7K citations